Histamine H2 Receptor Antagonists and Heart Failure Risk in Postmenopausal Women: The Women’s Health Initiative

Histamine H2 Receptor Antagonists and Heart Failure Risk in Postmenopausal Women: The Women’s Health Initiative

BACKGROUND: Prior studies suggested lower risk of heart failure (HF) in individuals taking H2 receptor antagonists (H2RA) compared with H2RA nonusers in relatively small studies. We evaluated the association of H2RA use and incident HF in post-menopausal women in the large-scale WHI (Women’s Health...

Full description

Bibliographic Details
Main Authors: Anderson, G. (Author), Branch, K.R (Author), Cheng, R.K (Author), Haring, B. (Author), Johnson, K.C (Author), Larson, S.R (Author), Leary, P.J (Author), Manson, J.E (Author), Reding, K.W (Author), Shadyab, A.H (Author), Vasbinder, A.L (Author), Wallace, R. (Author)
Format: Article
Language:English
Published: American Heart Association Inc. 2022
Subjects:
heart failure
postmenopausal women
prevention
Online Access:View Fulltext in Publisher

Similar Items

Similar Items